At the Colorado Center for Gynecologic Oncology, we are are keenly interested in new studies that can benefit our patients. Read below for more information on a study on PARB inhibitors in ovarian cancer. Study identifies subgroup for whom another go could be worthwhile Lack of response to a PARP inhibitor in epithelial ovarian cancer…
Details
Language is a powerful tool to describe and convey our thoughts. Interpretations of what is heard can vary from each listener. Sometimes, well intentioned words can create meanings that were not intended. Read below for some insights on how the language around cancer patients is interpreted and readers response to cancer language. ‘I needed someone…
Details
At the Colorado Center for Gynecological Oncology, we are always interested in new research studies and their findings. The article below reports on the Women Choosing Surgical Prevention (WISP) trial that began in 2016. Read below for more information on the trial and patient feedback. SGO 2019: Less Worry, More Symptoms and Regret With Risk-Reducing…
Details
Maintenance therapy for cancer patients should improve their quality of life while their cancer is in remission. Read below for details on a new study that shows that Niraparib extends time without symptoms for women with recurrent ovarian cancer. Niraparib maintenance therapy prolonged the time without symptoms or toxicity compared with placebo among women with…
Details
The Colorado Center for Gynecologic Oncology is excited to share our April Newsletter providing patients with new information, upcoming events and inspiring stories.